tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Avidity Biosciences downgraded to Neutral from Buy at Roth Capital
PremiumThe FlyAvidity Biosciences downgraded to Neutral from Buy at Roth Capital
2d ago
Merck says FDA approves updated indication for WINREVAIR
Premium
The Fly
Merck says FDA approves updated indication for WINREVAIR
2d ago
Merck: FDA grants priority review for two sBLAs for Keytruda, Keytruda Qlex
Premium
The Fly
Merck: FDA grants priority review for two sBLAs for Keytruda, Keytruda Qlex
6d ago
Evaxion Biotech price target raised to $11 from $6 at Lake Street
PremiumThe FlyEvaxion Biotech price target raised to $11 from $6 at Lake Street
9d ago
Merck begins construction on $3B manufacturing facility in Virginia
Premium
The Fly
Merck begins construction on $3B manufacturing facility in Virginia
9d ago
IO Biotech reports expanded Cylembio results
Premium
The Fly
IO Biotech reports expanded Cylembio results
9d ago
Merck reports Phase 3 ovarian cancer trial meets survival endpoint
PremiumThe FlyMerck reports Phase 3 ovarian cancer trial meets survival endpoint
13d ago
Merck presents data from Phase 3 studies of doravirine/islatravir
Premium
The Fly
Merck presents data from Phase 3 studies of doravirine/islatravir
14d ago
Merck resumed with a Neutral at Citi
Premium
The Fly
Merck resumed with a Neutral at Citi
16d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100